Literature DB >> 19118213

Integrins in mammary-stem-cell biology and breast-cancer progression--a role in cancer stem cells?

Stephanie M Pontier1, William J Muller.   

Abstract

Cancer cells with stem cell-like properties (cancer stem cells) are believed to drive cancer and are associated with poor prognosis. Data from mouse models have demonstrated that integrins, the major cellular receptors for extracellular-matrix components, have essential roles both during cancer initiation and progression, and during cell differentiation in normal development. By presenting an overview of the role of integrins in stem-cell biology and in cancer progression, this Commentary aims to present evidence for a role of integrins in the biology of cancer stem cells. Given the recent interest in the role of integrins in breast-cancer initiation and progression, we focus on the role of the members of the integrin family and their coupled signaling pathways in mammary-gland development and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19118213      PMCID: PMC2714417          DOI: 10.1242/jcs.040394

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  76 in total

Review 1.  Current insights into the formation and breakdown of hemidesmosomes.

Authors:  Sandy H M Litjens; José M de Pereda; Arnoud Sonnenberg
Journal:  Trends Cell Biol       Date:  2006-06-06       Impact factor: 20.808

2.  p63 regulates an adhesion programme and cell survival in epithelial cells.

Authors:  Danielle K Carroll; Jason S Carroll; Chee-Onn Leong; Fang Cheng; Myles Brown; Alea A Mills; Joan S Brugge; Leif W Ellisen
Journal:  Nat Cell Biol       Date:  2006-05-21       Impact factor: 28.824

Review 3.  Integrin signalling at a glance.

Authors:  David S Harburger; David A Calderwood
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

4.  Notch signaling regulates mammary stem cell function and luminal cell-fate commitment.

Authors:  Toula Bouras; Bhupinder Pal; François Vaillant; Gwyndolen Harburg; Marie-Liesse Asselin-Labat; Samantha R Oakes; Geoffrey J Lindeman; Jane E Visvader
Journal:  Cell Stem Cell       Date:  2008-10-09       Impact factor: 24.633

Review 5.  Nuclear reprogramming and pluripotency.

Authors:  Konrad Hochedlinger; Rudolf Jaenisch
Journal:  Nature       Date:  2006-06-29       Impact factor: 49.962

6.  Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.

Authors:  Wenjun Guo; Yuliya Pylayeva; Angela Pepe; Toshiaki Yoshioka; William J Muller; Giorgio Inghirami; Filippo G Giancotti
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

7.  Steroid hormone receptor status of mouse mammary stem cells.

Authors:  Marie-Liesse Asselin-Labat; Mark Shackleton; John Stingl; François Vaillant; Natasha C Forrest; Connie J Eaves; Jane E Visvader; Geoffrey J Lindeman
Journal:  J Natl Cancer Inst       Date:  2006-07-19       Impact factor: 13.506

Review 8.  Mechanisms that regulate adaptor binding to beta-integrin cytoplasmic tails.

Authors:  Kyle R Legate; Reinhard Fässler
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

9.  Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia.

Authors:  Nasreen Akhtar; Charles H Streuli
Journal:  J Cell Biol       Date:  2006-06-05       Impact factor: 10.539

10.  Perturbing integrin function inhibits microtubule growth from centrosomes, spindle assembly, and cytokinesis.

Authors:  Carlos G Reverte; Angela Benware; Christopher W Jones; Susan E LaFlamme
Journal:  J Cell Biol       Date:  2006-08-14       Impact factor: 10.539

View more
  37 in total

Review 1.  The normal microenvironment directs mammary gland development.

Authors:  Erin J McCave; Cheryl A P Cass; Karen J L Burg; Brian W Booth
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-09-08       Impact factor: 2.673

Review 2.  Cell-matrix interactions in mammary gland development and breast cancer.

Authors:  John Muschler; Charles H Streuli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

Review 3.  Integrins and cell-fate determination.

Authors:  Charles H Streuli
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

Review 4.  Mitochondria as therapeutic targets for cancer stem cells.

Authors:  In Sung Song; Jeong Yu Jeong; Seung Hun Jeong; Hyoung Kyu Kim; Kyung Soo Ko; Byoung Doo Rhee; Nari Kim; Jin Han
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

5.  A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.

Authors:  J L Little; V Serzhanova; E Izumchenko; B L Egleston; E Parise; A J Klein-Szanto; G Loudon; M Shubina; S Seo; M Kurokawa; M F Ochs; E A Golemis
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

6.  α7 helix region of αI domain is crucial for integrin binding to endoplasmic reticulum chaperone gp96: a potential therapeutic target for cancer metastasis.

Authors:  Feng Hong; Bei Liu; Gabriela Chiosis; Daniel T Gewirth; Zihai Li
Journal:  J Biol Chem       Date:  2013-05-13       Impact factor: 5.157

7.  Modulation of membrane properties of lung cancer cells by azurin enhances the sensitivity to EGFR-targeted therapy and decreased β1 integrin-mediated adhesion.

Authors:  Nuno Bernardes; Sofia Abreu; Filomena A Carvalho; Fábio Fernandes; Nuno C Santos; Arsénio M Fialho
Journal:  Cell Cycle       Date:  2016-04-20       Impact factor: 4.534

Review 8.  Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.

Authors:  Giampaolo Bianchini; Justin M Balko; Ingrid A Mayer; Melinda E Sanders; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2016-05-17       Impact factor: 66.675

Review 9.  Bidirectional extracellular matrix signaling during tissue morphogenesis.

Authors:  Nikolce Gjorevski; Celeste M Nelson
Journal:  Cytokine Growth Factor Rev       Date:  2009-11-06       Impact factor: 7.638

10.  The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.

Authors:  Nisha M Badders; Shruti Goel; Rod J Clark; Kristine S Klos; Soyoung Kim; Anna Bafico; Charlotta Lindvall; Bart O Williams; Caroline M Alexander
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.